By extension, associations of the KIR polymorphisms have been reported in a number of meta-analyses that included disease endpoints such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes mellitus and multiple sclerosis [54–57]. The gene discussed is KIR3DL1; the disease is diabetes mellitus.